Memorex 2012 Annual Report Download - page 21

Download and view the complete annual report

Please find page 21 of the 2012 Memorex annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 116

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity
Securities.
(a) — (b)
As of March 6, 2013, there were 41,508,767 shares of our common stock, $0.01 par value (common stock), outstanding
and held by 20,009 shareholders of record. Our common stock is listed on the New York Stock Exchange and the Chicago
Stock Exchange under the symbol “IMN.” No dividends were declared or paid during 2012 or 2011. Future dividend payments
will depend on our earnings, capital requirements, financial condition and other factors considered relevant by our Board of
Directors.
Unregistered Sales of Equity Securities
On December 31, 2012, Imation Corp. entered into an agreement to purchase Nexsan. A portion of the consideration
paid to Nexsan consisted of 3,319,324 shares of our common stock. The issuance of such shares was exempt from
registration under the Securities Act of 1933, as amended (Securities Act), pursuant to Section 4 (2) of the Securities Act. The
Company filed a registration statement on Form S-3 under the Securities Act for the resale of such shares.
The following table sets forth, for the periods indicated, the high and low sales prices of common stock as reported on
the New York Stock Exchange.
2012 Sales Prices 2011 Sales Prices
High Low High Low
First quarter ..................................... $6.42 $5.67 $12.36 $9.81
Second quarter ................................... $6.30 $5.54 $11.97 $8.50
Third quarter ..................................... $5.98 $5.40 $ 9.98 $6.64
Fourth quarter .................................... $5.69 $3.95 $ 8.00 $5.40
(c)
Issuer Purchases of Equity Securities
Period
(a)
Total Number
of Shares
Purchased
(b)
Average
Price Paid
per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
(c)
Maximum Number
of Shares that May
Yet Be Purchased
Under the Plan or
Programs
October 1, 2012—October 31, 2012 .................... — $ — — 4,159,830
November 1, 2012—November 30, 2012 ................ 295,242 4.12 291,506 3,868,324
December 1, 2012—December 31, 2012 ................ 106,124 4.37 104,485 3,763,839
Total ........................................... 401,366 $4.19 395,991 3,763,839
(a) The purchases in this column include shares repurchased as part of our publicly announced programs and include 5,375
shares that were surrendered to Imation by participants in our stock-based compensation plans (the Plans) to satisfy the
tax obligations related to the vesting of restricted stock awards.
(b) The average price paid in this column includes shares repurchased as part of our publicly announced programs and
shares that were surrendered to Imation by participants in the Plans to satisfy the tax obligations related to the vesting of
restricted stock awards.
(c) On May 3, 2012, the Company announced that on May 2, 2012 our Board of Directors authorized a share repurchase
program of 5 million shares of common stock. The authorization has no expiration date. The Company’s previous
authorization, which had 1.2 million shares remaining for purchase, was canceled with the new authorization.
18